Propionibacterium freudenreichii CIRM-BIA 129 mitigates colitis through S layer protein B-dependent epithelial strengthening.
- 2024-02-01
- Clinical Trial
- American Journal of Physiology-Gastrointestinal and Liver Physiology 326(2)
- Marine Mantel
- Tony Durand
- A. Bessard
- Ségolène Pernet
- Julie Beaudeau
- Juliana Guimaraes-Laguna
- Marie-Bernadette Maillard
- Éric Guédon
- Michel Neunlist
- Yves Le-Loir
- Gwénaël Jan
- M. Rolli-Derkinderen
- PubMed: 37988603
- DOI: 10.1152/ajpgi.00198.2023
- Low evidence
- Animal Study
It increased transepithelial electrical resistance (TEER) and inhibited permeability induced by inflammation, along with an increased ZO-1 expression.
- Effect
- Beneficial
- Effect size
- Moderate